Ghent University Academic Bibliography

Your filters: cql: parent exact "NPJ VACCINES"

Add to list
- Journal Article
- A1
- open access
Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza

Xiaole Cui (UGent) , Pieter Vervaeke (UGent) , Ya Gao (UGent) , Lisa Opsomer, Qing Sun (UGent) , Janne Snoeck (UGent) , Bert Devriendt (UGent) , Zifu Zhong (UGent) and Niek Sanders (UGent)

(2024) NPJ VACCINES. 9(1).
Add to list
- Journal Article
- A1
- open access
QuilA® adjuvanted Coxevac® sustains Th1-CD8+-type immunity and increases protection in Coxiella burnetii-challenged goats

Sara Tomaiuolo (UGent) , Wiebke Jansen, Susana Soares Martins, Bert Devriendt (UGent) , Eric Cox (UGent) and Marcella Mori

(2023) NPJ VACCINES. 8(1).
Add to list
- Journal Article
- A1
- open access
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase

João Paulo Portela Catani, Emma Job (UGent) , Tine Ysenbaert (UGent) , Anouk Smet (UGent) , Satyajit Ray, Lauren LaRue, Svetlana Stegalkina, Mario Barro, Thorsten U. Vogel and Xavier Saelens (UGent)

(2022) NPJ VACCINES. 7(1).
Add to list
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) NPJ VACCINES. 5(1).
Add to list
- Journal Article
- A1
- open access
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon, Iain Welsby, Sophie Detienne, Mary van Helden (UGent) , Sheetij Dutta, Christopher J Genito, Norman C Waters, et al.

(2017) NPJ VACCINES. 2(1).
Add to list
- Journal Article
- A1
- open access
Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection

Kristien Van Reeth (UGent) , José Carlos Mancera Gracia (UGent) , Ivan Trus (UGent) , Lieve Sys (UGent) , Gerwin Claes (UGent) , Han Versnaeyen (UGent) , Eric Cox (UGent) , Florian Krammer and Yu Qiu (UGent)

(2017) NPJ VACCINES. 2.

Academic Bibliography

Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza

QuilA® adjuvanted Coxevac® sustains Th1-CD8+-type immunity and increases protection in Coxiella burnetii-challenged goats

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase

Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection

Contents

Support

Contact